Stock · HCA · Healthcare
United States · Large Cap · listed since 2011 · Revenue 12 mo. $78B
Price as of 11/06/2026
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Original text from the data provider
Summary
53.0 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €6.9B (2025), it supports €76.7B. The remaining €17.2B of the market value assume it grows 2.9% a year for 10 years and not at all afterwards.
Required FCF growth per year
2.9%
no growth afterwards
Price to operating cash flow 9.9×, above its usual range.
Middle half of 20 quarters: 7.8× to 8.9×, median 8.3×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
No anomaly in the stored figures.
Since the last quarter
Q1 → Q2 2026
3 more unchanged: Revenue, 12 mo., EBIT margin, Net debt
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | −123.20% | 11.52% | Rank 3 |
| Return on capital (Greenblatt) | 38.42% | 32.55% | Rank 61 |
| EBIT margin | 15.83% | 18.31% | Rank 44 |
| FCF margin | 10.17% | 14.12% | Rank 36 |
| Gross margin | 41.50% | 60.99% | Rank 26 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 7.08% | 8.04% | Rank 46 |
| Earnings growth, 3 years per year | 15.37% | 5.44% | Rank 70 |
| Earnings growth, 5 years per year | 22.02% | 7.00% | Rank 87 |
| Sustainable growth (ROE × retained earnings) | 6.54% | 3.66% | Rank 80 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 5.94% | 2.90% | Rank 86 |
| FCF yield | 7.35% | 3.63% | Rank 87 |
| EV/saleslower is better | 2.01 | 4.03 | Rank 76 |
| EV/EBITlower is better | 12.73 | 21.73 | Rank 85 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | −4.59% | 8.66% | Rank 35 |
| Share price, 6 months | 14.22% | 24.27% | Rank 34 |
| Share price, 3 months | 24.88% | 15.42% | Rank 81 |
| Distance from 52-week high | −9.20% | −7.35% | Rank 43 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | −1.44% | 0.30% | Rank 67 |
| Change in share countlower is better | −11.88% | 0.00% | Rank 99 |
| Dividend streak in years | 5 | 10 | Rank 51 |
| Price reaction to results, market-adjusted | −3.95% | 0.05% | Rank 18 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | −4.56% | 48.40% | Rank 2 |
| Net debt/EBITDAlower is better | 3.05 | 1.11 | Rank 15 |
| Debt to equitylower is betterdoes not count towards the rank | −7.91 | 0.48 | |
| Volatility, 1 yearlower is better | 31.26% | 31.42% | Rank 51 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF, $B | Shares | Net debt, $B |
|---|---|---|---|---|---|
| 2016 | 41.5 | 14.9% | 2.9 | 396M | 30.7 |
| 2017 | 43.6 | 13.9% | 2.4 | 372M | 32.3 |
| 2018 | 46.7 | 14.2% | 3.2 | 355M | 32.3 |
| 2019 | 51.3 | 14.1% | 3.4 | 348M | 35.0 |
| 2020 | 51.5 | 14.1% | 6.4 | 345M | 31.3 |
| 2021 | 58.8 | 16.5% | 5.4 | 329M | 35.3 |
| 2022 | 60.2 | 15.0% | 4.1 | 295M | 39.3 |
| 2023 | 65.0 | 14.8% | 4.7 | 276M | 40.9 |
| 2024 | 70.6 | 14.9% | 5.6 | 262M | 43.3 |
| 2025 | 75.6 | 15.8% | 7.7 | 231M | 49.2 |
3 of 7 StockScorer Score rules met · How the score is built
HCA Healthcare, Inc. mainly meets criteria in the Valuation category. Result from 18 strategies checked.
HCA Healthcare, Inc. is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
3 of 7 rules met
5 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for HCA Healthcare, Inc.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 16.8 | 30.0 |
| P/B ratio | −16.1 | 4.8 |
| Return on equity (ROE) | −123.2% | 11.5% |
| Equity ratio | −4.6% | 48.4% |
| Debt-to-equity (D/E) | −7.91 | 0.48 |
| Dividend yield | 0.6% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| HCA | HCA Healthcare, Inc.this page | |
| FRE.DE | Fresenius SE & Co. KGaA | Low1.8 |
| THC | Tenet Healthcare Corporation | locked |
| 4013.SR | Dr Sulaiman Al Habib Medical Group | locked |
| 5225.KL | IHH Healthcare Bhd | locked |
| EHC | Encompass Health Corp | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.